Search the Appendices of Resolution CM/Res(2018)1
3971 found
| INN | ATC Code ▼ | Classification | Last update | |
|---|---|---|---|---|
| AMINOLEVULINIC ACID | L01XD04 | POM | ||
| METHYL AMINOLEVULINATE | L01XD03 | Currently not available | ||
| PORFIMER SODIUM | L01XD01 | I | ||
| POLATUZUMAB VEDOTIN | L01XC37 | Currently not available | ||
| DURVALUMABUM | L01XC28 | Currently not available | ||
| CETUXIMAB | L01XC06 | I | ||
| TRASTUZUMAB | L01XC03 | I | ||
| RITUXIMAB | L01XC02 | Currently not available | ||
| PROCARBAZINE | L01XB01 | I | 25-02-2009 | |
| OXALIPLATIN | L01XA03 | I | 28-07-2004 | |
| CARBOPLATIN | L01XA02 | I | ||
| CISPLATIN | L01XA01 | I | 28-07-2004 | |
| NIVOLUMAB AND RELATLIMAB | L01FY02 | I | ||
| PERTUZUMAB AND TRASTUZUMAB | L01FY01 | I | ||
| ELRANATAMAB | L01FX32 | I | ||
| ZOLBETUXIMAB | L01FX31 | POM | ||
| TALQUETAMAB | L01FX29 | I | ||
| GLOFITAMAB | L01FX28 | I | ||
| EPCORITAMAB | L01FX27 | Currently not available | ||
| MIRVETUXIMAB SORAVTANSINE | L01FX26 | POM | ||
| MOSUNETUZUMAB | L01FX25 | Currently not available | ||
| TECLISTAMAB | L01FX24 | Currently not available | ||
| LONCASTUXIMAB TESIRINE | L01FX22 | I | ||
| TREMELIMUMAB | L01FX20 | I | ||
| AMIVANTAMAB | L01FX18 | I | ||
| SACITUZUMAB GOVITECAN | L01FX17 | I | ||
| POLATUZUMAB VEDOTIN | L01FX14 | I | ||
| ENFORTUMAB VEDOTIN | L01FX13 | POM | ||
| TAFASITAMAB | L01FX12 | I | ||
| OLARATUMAB | L01FX10 | Currently not available | ||
| MOGAMULIZUMAB | L01FX09 | I | ||
| ELOTUZUMAB | L01FX08 | I | ||
| BLINATUMOMAB | L01FX07 | I | ||
| DINUTUXIMAB BETA | L01FX06 | I | ||
| BRENTUXIMAB VEDOTIN | L01FX05 | I | ||
| IPILIMUMAB | L01FX04 | I | 02-12-2015 | |
| CATUMAXOMAB | L01FX03 | POM | ||
| GEMTUZUMAB OZOGAMICIN | L01FX02 | I | ||
| RAMUCIRUMAB | L01FG02 | I | 12-04-2019 | |
| BEVACIZUMAB | L01FG01 | Currently not available | ||
| TORIPALIMAB | L01FF13 | POM | ||
| SERPLULIMAB | L01FF12 | POM | ||
| SUGEMALIMAB | L01FF11 | Currently not available | ||
| RETIFANLIMAB | L01FF10 | POM | ||
| TISLELIZUMAB | L01FF09 | I | 23-05-2024 | |
| DOSTARLIMAB | L01FF07 | I | ||
| CEMIPLIMAB | L01FF06 | I | ||
| ATEZOLIZUMAB | L01FF05 | I | ||
| AVELUMAB | L01FF04 | I | ||
| DURVALUMAB | L01FF03 | I | 12-04-2019 |